Despite the significant achievements in chemotherapy, cancer remains one of the leading causes of death. Target therapy revolutionized this field, but efficiencies of target drugs show dramatic variation among individual patients. Personalization of target therapies remains, therefore, a challenge in oncology. We are working on drug discovery process that will help to recommend the drug according to mutation rate in patient. Mutation rate helps to identify the stage of disease. Besides that, we are also working on drug-gene association prediction that will help to know that how much a drug will affect a particular gene.
Posted on: May 8, 2020